A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

doi:10.1186/bcr1602

Research article

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

David G Cox^*, Hélène Blanché, Celeste L Pearce, Eugenia E Calle, Graham A Colditz, Malcolm C Pike, Demetrius Albanes, Naomi E Allen, Pilar Amiano, Goran Berglund, Heiner Boeing, Julie Buring, Noel Burtt, Federico Canzian, Stephen Chanock, Françoise Clavel-Chapelon, Heather S Feigelson, Matthew Freedman, Christopher A Haiman, Susan E Hankinson, Brian E Henderson, Robert Hoover, David J Hunter, Rudolf Kaaks, Laurence Kolonel, Peter Kraft, Loic LeMarchand, Eiliv Lund, Domenico Palli, Petra HM Peeters, Elio Riboli, Daniel O Stram, Michael Thun, Anne Tjonneland, Dimitrios Trichopoulos, Meredith Yeager and the Breast and Prostate Cancer Cohort Consortium

* Corresponding author: David G Cox dcox@hsph.harvard.edu

Breast Cancer Research 2006, 8:R54 doi:10.1186/bcr1602

No comments have yet been made on this article.

Breast Cancer Research

Viewing options

Associated material

Tools

Share this article

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

Breast Cancer Research

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)